| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.29 | 0.08 |